Abuqayyas, L., & Balthasar, J. P. (2012).,Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.,Journal of Pharmacokinetics and Pharmacodynamics, 39(6), 683-710. doi:10.1007/s10928-012-9279-8 [doi]
    Amodio, N., Stamato, M. A., Gulla, A. M., Morelli, E., Romeo, E., Raimondi, L., . . . Tassone, P. (2016).,Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma.,Molecular Cancer Therapeutics, 15(6), 1364-1375. doi:10.1158/1535-7163.MCT-15-0985 [doi]
    Aregueta-Robles, U., Fajardo-Ramirez, O. R., Villela, L., Gutierrez-Uribe, J. A., Hernandez-Hernandez, J., Lopez-Sanchez, R. D. C., . . . Serna-Saldivar, S. (2018).,Cytotoxic activity of a black bean (phaseolus vulgaris L.) extract and its flavonoid fraction in both in vitro and in vivo models of lymphoma.,Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 70(1), 32-39. doi:10.24875/RIC.17002395 [doi]
    Ashley, J. D., Stefanick, J. F., Schroeder, V. A., Suckow, M. A., Alves, N. J., Suzuki, R., . . . Bilgicer, B. (2014).,Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo,Journal of Controlled Release : Official Journal of the Controlled Release Society, 196, 113-121. doi:10.1016/j.jconrel.2014.10.005 [doi]
    Balkin, E. R., Liu, D., Jia, F., Ruthengael, V. C., Shaffer, S. M., Miller, W. H., & Lewis, M. R. (2014).,Comparative biodistributions and dosimetry of [(1)(7)(7)lu]DOTA-anti-bcl-2-PNA-tyr(3)-octreotate and [(1)(7)(7)lu]DOTA-tyr(3)-octreotate in a mouse model of B-cell lymphoma/leukemia.,Nuclear Medicine and Biology, 41(1), 36-42. doi:10.1016/j.nucmedbio.2013.10.006 [doi]
    Chu, K. S., Hasan, W., Rawal, S., Walsh, M. D., Enlow, E. M., Luft, J. C., . . . DeSimone, J. M. (2013).,Plasma, tumor and tissue pharmacokinetics of docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.,Nanomedicine : Nanotechnology, Biology, and Medicine, 9(5), 686-693. doi:10.1016/j.nano.2012.11.008 [doi]
    Cocco, E., Shapiro, E. M., Gasparrini, S., Lopez, S., Schwab, C. L., Bellone, S., . . . Santin, A. D. (2015).,Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer,International Journal of Cancer, 137(11), 2618-2629. doi:10.1002/ijc.29632 [doi]
    Daniluk, U., Kerros, C., Tao, R. H., Wise, J. F., Ao, X., Berkova, Z., & Samaniego, F. (2012),The peptide derived from the ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.,Journal of Experimental & Clinical Cancer Research : CR, 31, 69-9966-31-69. doi:10.1186/1756-9966-31-69 [doi]
    Dembinski, J. L., Wilson, S. M., Spaeth, E. L., Studeny, M., Zompetta, C., Samudio, I., . . . Marini, F. C. (2013).,Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer,Cytotherapy, 15(1), 20-32. doi:10.1016/j.jcyt.2012.10.003 [doi]
    Di Martino, M. T., Leone, E., Amodio, N., Foresta, U., Lionetti, M., Pitari, M. R., . . . Tassone, P. (2012).,Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(22), 6260-6270. doi:10.1158/1078-0432.CCR-12-1708 [doi]
    Dingli, D., Diaz, R. M., Bergert, E. R., O'Connor, M. K., Morris, J. C., & Russell, S. J. (2003).,Genetically targeted radiotherapy for multiple myeloma,Blood, 102(2), 489-496. doi:10.1182/blood-2002-11-3390 [doi]
    Dingli, D., Timm, M., Russell, S. J., Witzig, T. E., & Rajkumar, S. V. (2002).,Promising preclinical activity of 2-methoxyestradiol in multiple myeloma,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 8(12), 3948-3954.
    Do, T. V., Hirst, J., Hyter, S., Roby, K. F., & Godwin, A. K. (2017).,. Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells.,Oncotarget, 8(31), 50376-50392. doi:10.18632/oncotarget.18970 [doi]
    Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., . . . Wahl, A. F. (2003).,cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.,Blood, 102(4), 1458-1465. doi:10.1182/blood-2003-01-0039 [doi]
    Glaser, G., Weroha, S. J., Becker, M. A., Hou, X., Enderica-Gonzalez, S., Harrington, S. C., & Haluska, P. (2015).,Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft,PloS One, 10(5), e0126867. doi:10.1371/journal.pone.0126867 [doi]
    Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., . . . Roberts, R. D. (2018),L-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.,JCI Insight, 3(16), 10.1172/jci.insight.99791. doi:10.1172/jci.insight.99791 [doi]
    Gunawardane, R. N., Nepomuceno, R. R., Rooks, A. M., Hunt, J. P., Ricono, J. M., Belli, B., & Armstrong, R. C. (2013),Transient exposure to quizartinib mediates sustained inhibition of FLT3 signaling while specifically inducing apoptosis in FLT3-activated leukemia cells,Molecular Cancer Therapeutics, 12(4), 438-447. doi:10.1158/1535-7163.MCT-12-0305 [doi]
    Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M., Lenox, J., Cerveny, C. G., . . . Francisco, J. A. (2004).,Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 10(20), 7063-7070. doi:10/20/7063 [pii]
    Jafri, S. H., Glass, J., Shi, R., Zhang, S., Prince, M., & Kleiner-Hancock, H. (2010).,Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.,Journal of Experimental & Clinical Cancer Research : CR, 29, 87-9966-29-87. doi:10.1186/1756-9966-29-87 [doi]
    Jeffrey, S. C., Burke, P. J., Lyon, R. P., Meyer, D. W., Sussman, D., Anderson, M., . . . Senter, P. D. (2013).,A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology.,Bioconjugate Chemistry, 24(7), 1256-1263. doi:10.1021/bc400217g [doi]
    Jia, F., Balaji, B. S., Gallazzi, F., & Lewis, M. R. (2015).,Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.,Nuclear Medicine and Biology, doi:S0969-8051(15)00094-3 [pii]
    Junttila, T. T., Akita, R. W., Parsons, K., Fields, C., Lewis Phillips, G. D., Friedman, L. S., . . . Sliwkowski, M. X. (2009).,Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941.,Cancer Cell, 15(5), 429-440. doi:10.1016/j.ccr.2009.03.020 [doi]
    Kiziltepe, T., Ashley, J. D., Stefanick, J. F., Qi, Y. M., Alves, N. J., Handlogten, M. W., . . . Bilgicer, B. (2012).,Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo,Blood Cancer Journal, 2(4), e64. doi:10.1038/bcj.2012.10 [doi]
    Kryeziu, K., Pirker, C., Englinger, B., van Schoonhoven, S., Spitzwieser, M., Mohr, T., . . . Heffeter, P. (2016),Chronic arsenic trioxide exposure leads to enhanced aggressiveness via met oncogene addiction in cancer cells,Oncotarget, 7(19), 27379-27393. doi:10.18632/oncotarget.8415 [doi]
    Kung Sutherland, M. S., Walter, R. B., Jeffrey, S. C., Burke, P. J., Yu, C., Kostner, H., . . . McEarchern, J. A. (2013).,SGN-CD33A: A novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.,Blood, 122(8), 1455-1463. doi:10.1182/blood-2013-03-491506 [doi]
    Li, Y., Williams, M. E., Cousar, J. B., Pawluczkowycz, A. W., Lindorfer, M. A., & Taylor, R. P. (2007).,Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models.,Journal of Immunology (Baltimore, Md.: 1950), 179(6), 4263-4271. doi:179/6/4263 [pii]
    Lu, A., Pallero, M. A., Lei, W., Hong, H., Yang, Y., Suto, M. J., & Murphy-Ullrich, J. E. (2016),Inhibition of transforming growth factor-beta activation diminishes tumor progression and osteolytic bone disease in mouse models of multiple myeloma.,The American Journal of Pathology, 186(3), 678-690. doi:10.1016/j.ajpath.2015.11.003 [doi]
    Lyon, R. P., Bovee, T. D., Doronina, S. O., Burke, P. J., Hunter, J. H., Neff-LaFord, H. D., . . . Senter, P. D. (2015).,Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index.,Nature Biotechnology, 33(7), 733-735. doi:10.1038/nbt.3212 [doi]
    Lyon, R. P., Setter, J. R., Bovee, T. D., Doronina, S. O., Hunter, J. H., Anderson, M. E., . . . Senter, P. D. (2014).,Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.,Nature Biotechnology, 32(10), 1059-1062. doi:10.1038/nbt.2968 [doi]
    Mahasreshti, P. J., Navarro, J. G., Kataram, M., Wang, M. H., Carey, D., Siegal, G. P., . . . Curiel, D. T. (2001),Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 7(7), 2057-2066.
    McEarchern, J. A., Smith, L. M., McDonagh, C. F., Klussman, K., Gordon, K. A., Morris-Tilden, C. A., . . . Law, C. L. (2008).,. Preclinical characterization of SGN-70, a humanized antibody directed against CD70.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(23), 7763-7772. doi:10.1158/1078-0432.CCR-08-0493 [doi]
    Morelli, E., Leone, E., Cantafio, M. E., Di Martino, M. T., Amodio, N., Biamonte, L., . . . Tassone, P. (2015).,Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo,Leukemia, 29(11), 2173-2183. doi:10.1038/leu.2015.124 [doi]
    Peng, K. W., Ahmann, G. J., Pham, L., Greipp, P. R., Cattaneo, R., & Russell, S. J. (2001).,Systemic therapy of myeloma xenografts by an attenuated measles virus.,Blood, 98(7), 2002-2007.
    Pepin, K. M., Chen, J., Glaser, K. J., Mariappan, Y. K., Reuland, B., Ziesmer, S., . . . McGee, K. P. (2014).,MR elastography derived shear stiffness--a new imaging biomarker for the assessment of early tumor response to chemotherapy.,Magnetic Resonance in Medicine, 71(5), 1834-1840. doi:10.1002/mrm.24825 [doi]
    Romani, C., Cocco, E., Bignotti, E., Moratto, D., Bugatti, A., Todeschini, P., . . . Mitola, S. (2015),Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery,Oncotarget, 6(33), 34617-34628. doi:10.18632/oncotarget.5315 [doi]
    Ryan, M. C., Palanca-Wessels, M. C., Schimpf, B., Gordon, K. A., Kostner, H., Meyer, B., . . . Benjamin, D. (2017).,Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies.,Blood, 130(18), 2018-2026. doi:10.1182/blood-2017-04-779389 [doi]
    Santin, A. D., Cane, S., Bellone, S., Palmieri, M., Siegel, E. R., Thomas, M., . . . Pecorelli, S. (2005).,Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of clostridium perfringens enterotoxin.,Cancer Research, 65(10), 4334-4342. doi:65/10/4334 [pii]
    Smith, R. C., Cramer, M. S., Mitchell, P. J., Capen, A., Huber, L., Wang, R., . . . Heuer, J. G. (2015).,Myostatin neutralization results in preservation of muscle mass and strength in preclinical models of tumor-induced muscle wasting.,Molecular Cancer Therapeutics, 14(7), 1661-1670. doi:10.1158/1535-7163.MCT-14-0681 [doi]
    Sutherland, M. K., Yu, C., Lewis, T. S., Miyamoto, J. B., Morris-Tilden, C. A., Jonas, M., . . . Law, C. L. (2009).,Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.,Mabs, 1(5), 481-490. doi:9288 [pii]
    Tabe, Y., Shi, Y. X., Zeng, Z., Jin, L., Shikami, M., Hatanaka, Y., . . . Konopleva, M. (2013).,TGF-beta-neutralizing antibody 1D11 enhances cytarabine-induced apoptosis in AML cells in the bone marrow microenvironment.,PloS One, 8(6), e62785. doi:10.1371/journal.pone.0062785 [doi]
    Taylor, C. A., Liu, Z., Tang, T. C., Zheng, Q., Francis, S., Wang, T. W., . . . Thompson, J. E. (2012).,Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-kappaB activity and tumor growth in murine models of multiple myeloma,Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(7), 1305-1314. doi:10.1038/mt.2012.94 [doi]
    Zhang, C. C., Pavlicek, A., Zhang, Q., Lira, M. E., Painter, C. L., Yan, Z., . . . Christensen, J. G. (2012).,Biomarker and pharmacologic evaluation of the gamma-secretase inhibitor PF-03084014 in breast cancer models.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(18), 5008-5019. doi:10.1158/1078-0432.CCR-12-1379 [doi]
    Zhang, L., Nomie, K., Zhang, H., Bell, T., Pham, L., Kadri, S., . . . Wang, M. (2017),B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(15), 4212-4223. doi:10.1158/1078-0432.CCR-16-2703 [doi]
    Zhang, L., Pham, L. V., Newberry, K. J., Ou, Z., Liang, R., Qian, J., . . . Wang, M. (2013).,In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: Targeting the immunoproteasome.,Molecular Cancer Therapeutics, 12(11), 2494-2504. doi:10.1158/1535-7163.MCT-13-0156 [doi]
    Bhatta, Puspanjali; Dhukhwa, Asmita; Sheehan, Kelly; Al Aameri, Raheem F H; Borse, Vikrant; Ghosh, Sumana; Sheth, Sandeep; Mamillapalli, Chaitanya; Rybak, Leonard; Ramkumar, Vickram; Mukherjea, Debashree;,Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.,Scientific reports Vol.9, 2019
    Cai D, Wang J, Gao B, Li J, Wu F, Zou JX, Xu J, Jiang Y, Zou H, Huang Z, Borowsky AD, Bold RJ, Lara PN, Li JJ, Chen X, Lam KS, To KF, Kung HJ, Fiehn O, Zhao R, Evans RM, Chen HW,RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype.,Nat Commun. 2019 Oct 11;10(1):4621.
    Han, Chanhee; Perrone, Emanuele; Zeybek, Burak; Bellone, Stefania; Tymon-Rosario, Joan; Altwerger, Gary; Menderes, Gulden; Feinberg, Jacqueline; Haines, Kaitlin; Muller Karger, Mariana Espinal; Bianchi, Anna; Zammataro, Luca; Manzano, Aranzazu; Bonazzoli, Elena; Manara, Paola; Buza, Natalia; Hui, Pei; Ratner, Elena; Silasi, Dan-Arin; Huang, Gloria S; Azodi, Masoud; Schwartz, Peter E; Lopez, Salvatore; Santin, Alessandro D,In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.,Gynecologic oncology Vol.10, 2019
    Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, Antonio MJ, Camelo F, Li T, Nguyen S, Hoang G, Nguyen K, Udupa S, Sazeides C, Shen YA, Elgogary A, Reyes J, Zhao L, Kleensang A, Chaichana KL, Hartung T, Betenbaugh MJ, Marie SK, Jung JG, Wang TL, Gabrielson E, Le A,Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.,Cell Rep. 2019 Apr 9;27(2):491-501.e6.
    Pfitzer L, Moser C, Gegenfurtner F, Arner A, Foerster F, Atzberger C, Zisis T, Kubisch-Dohmen R, Busse J, Smith R, Timinszky G, Kalinina OV, Müller R, Wagner E, Vollmar AM, Zahler S.,Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy.,Cell Death Dis. 2019 Apr 3;10(4):302.
    Wang, Yongqiang; Huang, Zenghong; Chen, Christopher Z; Liu, Chengfei; Evans, Christopher P; Gao, Allen C; Zhou, Fangjian; Chen, Hong-Wu;,herapeutic targeting MDR1 expression by RORγ antagonists resensitizes cross-resistant CRPC to taxane via coordinated induction of cell death programs.,Molecular cancer therapeutics Vol.10, 2019

    General Studies

    Li, Fu; Ulrich, Michelle L; Shih, Vincent Feng-Sheng; Cochran, Julia H; Hunter, Joshua H; Westendorf, Lori; Neale, Jason; Benjamin, Dennis R;,Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction.,Molecular cancer therapeutics Vol.18, 2019


    Fang, R., Ismail, N., & Walker, D. H. (2012).,Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium.,The American Journal of Pathology, 181(1), 185-195. doi:10.1016/j.ajpath.2012.03.020 [doi]
    Gill, S., Vasey, A. E., De Souza, A., Baker, J., Smith, A. T., Kohrt, H. E., . . . Negrin, R. S. (2012).,Negrin, R. S. (2012). Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells,Blood, 119(24), 5758-5768. doi:10.1182/blood-2012-03-415364 [doi]
    Hossain, M., Qadri, S. M., & Liu, L. (2012).,Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature,Journal of Inflammation (London, England), 9(1), 28-9255-9-28. doi:10.1186/1476-9255-9-28 [doi]
    Jones, R. J., Iempridee, T., Wang, X., Lee, H. C., Mertz, J. E., Kenney, S. C., . . . Orlowski, R. Z. (2016).,Lenalidomide, thalidomide, and pomalidomide reactivate the epstein-barr virus lytic cycle through phosphoinositide 3-kinase signaling and ikaros expression.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(19), 4901-4912. doi:1078-0432.CCR-15-2242 [pii]
    Liu, Z., Gunasekaran, K., Wang, W., Razinkov, V., Sekirov, L., Leng, E., . . . Yan, W. (2014).,Asymmetrical fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies.,The Journal of Biological Chemistry, 289(6), 3571-3590. doi:10.1074/jbc.M113.513366 [doi]
    Rogovskyy, A. S., Casselli, T., Tourand, Y., Jones, C. R., Owen, J. P., Mason, K. L., . . . Bankhead, T. (2015).,Evaluation of the importance of VlsE antigenic variation for the enzootic cycle of borrelia burgdorferi.,PloS One, 10(4), e0124268. doi:10.1371/journal.pone.0124268 [doi]
    Rosario, M., Liu, B., Kong, L., Collins, L. I., Schneider, S. E., Chen, X., . . . Fehniger, T. A. (2016).,he IL-15-based ALT-803 complex enhances FcgammaRIIIa-triggered NK cell responses and in vivo clearance of B cell lymphomas.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(3), 596-608. doi:10.1158/1078-0432.CCR-15-1419 [doi]
    Wallach-Dayan, S. B., Elkayam, L., Golan-Gerstl, R., Konikov, J., Zisman, P., Dayan, M. R., . . . Breuer, R. (2015),. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.,Journal of Autoimmunity, 59, 67-76. doi:10.1016/j.jaut.2015.02.006 [doi]
    Wintrob, Z. A., Oppong, E. K., Foster, M., Martorana, M., Tse, Y. C., Zhong, L., . . . Ceacareanu, A. C. (2014),Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model.,Cytokine, 67(2), 102-106. doi:10.1016/j.cyto.2014.02.011 [doi]
    Felder, Mildred; Kapur, Arvinder; Rakhmilevich, Alexander L; Qu, Xiaoyi; Sondel, Paul M; Gillies, Stephen D; Connor, Joseph; Patankar, Manish S,UC16 suppresses human and murine innate immune responses.,Gynecologic oncology Vol.152, 2019
    Manthey, Carl L; Moore, Beverley A; Chen, Yanqing; Loza, Matthew J; Yao, Xiang; Liu, Hao; Belkowski, Stanley M; Raymond-Parks, Holly; Dunford, Paul J; Leon, Francisco; Towne, Jennifer E; Plevy, Scott E;,The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis.,PloS one Vol.14, 2019


    Gill H, Seipert R, Carroll VM, Gouasmat A, Yin J, Ogasawara A, de Jong I, Phan MM, Wang X, Yang J, Ilovich O, Marik J, Williams SP,The Production, Quality Control, and Characterization of ZED8, a CD8-Specific,AAPS J. 2020 Jan 3;22(2):22.


    Folberg, R., Leach, L., Valyi-Nagy, K., Lin, A. Y., Apushkin, M. A., Ai, Z., . . . Maniotis, A. J. (2007).,Modeling the behavior of uveal melanoma in the liver.,Investigative Ophthalmology & Visual Science, 48(7), 2967-2974. doi:48/7/2967 [pii]
    Wang, Y. Y., Chatzistavrou, X., Faulk, D., Badylak, S., Zheng, L., Papagerakis, S., . . . Papagerakis, P. (2015),Biological and bactericidal properties of ag-doped bioactive glass in a natural extracellular matrix hydrogel with potential application in dentistry.,European Cells & Materials, 29, 342-355. doi:vol029a25 [pii]
    Weinmuellner, R., Kryeziu, K., Zbiral, B., Tav, K., Schoenhacker-Alte, B., Groza, D., . . . Heffeter, P. (2018).,Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements,Archives of Toxicology, 92(1), 181-194. doi:10.1007/s00204-017-2034-6 [doi]
    Yin, W., Kimbrough, C. W., Gomez-Gutierrez, J. G., Burns, C. T., Chuong, P., Grizzle, W. E., & McNally, L. R. (2015).,Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography.,Journal of Nanobiotechnology, 13, 90-015-0139-8. doi:10.1186/s12951-015-0139-8 [doi]
    Dong, Qing; Wang, Yuanyuan; Mohabatpour, Fatemeh; Zheng, Li; Papagerakis, Silvana; Chen, Daniel; Papagerakis, Petros,Dental Pulp Stem Cells: Isolation, Characterization, Expansion, and Odontoblast Differentiation for Tissue Engineering.,Methods in molecular biology (Clifton, N.J.) Vol.1922, 2019

    Tumor Cell Growth

    Alagpulinsa, D. A., Ayyadevara, S., Yaccoby, S., & Shmookler Reis, R. J. (2016).,A cyclin-dependent kinase inhibitor, dinaciclib, impairs homologous recombination and sensitizes multiple myeloma cells to PARP inhibition.,Molecular Cancer Therapeutics, 15(2), 241-250. doi:10.1158/1535-7163.MCT-15-0660 [doi]
    Ayuzawa, R., Doi, C., Rachakatla, R. S., Pyle, M. M., Maurya, D. K., Troyer, D., & Tamura, M. (2009),Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo,Cancer Letters, 280(1), 31-37. doi:10.1016/j.canlet.2009.02.011 [doi]
    Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., & Garen, A. (1995).,Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.,Proceedings of the National Academy of Sciences of the United States of America, 92(18), 8205-8209.
    Caso, J., Masko, E. M., Ii, J. A., Poulton, S. H., Dewhirst, M., Pizzo, S. V., & Freedland, S. J. (2013).,The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model.,The Prostate, 73(5), 449-454. doi:10.1002/pros.22586 [doi]
    Fernandes, M. S., Gomes, E. M., Butcher, L. D., Hernandez-Alcoceba, R., Chang, D., Kansopon, J., . . . Tong, A. W. (2009).,Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.,Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(15), 4847-4856. doi:10.1158/1078-0432.CCR-09-0451 [doi]
    Hansen, A. G., Arnold, S. A., Jiang, M., Palmer, T. D., Ketova, T., Merkel, A., . . . Zijlstra, A. (2014).,ALCAM/CD166 is a TGF-beta-responsive marker and functional regulator of prostate cancer metastasis to bone.,Cancer Research, 74(5), 1404-1415. doi:10.1158/0008-5472.CAN-13-1296 [doi]
    He, J., Liu, Z., Zheng, Y., Qian, J., Li, H., Lu, Y., . . . Yang, J. (2012).,p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction,Cancer Research, 72(24), 6393-6402. doi:10.1158/0008-5472.CAN-12-2664 [doi]
    He, Z., He, J., Liu, Z., Xu, J., Yi, S. F., Liu, H., & Yang, J. (2014),MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption,Biochimie, 106, 24-32. doi:10.1016/j.biochi.2014.07.017 [doi]
    Hudson, S. V., Huang, J. S., Yin, W., Albeituni, S., Rush, J., Khanal, A., . . . McNally, L. R. (2014).,Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography.,Cancer Research, 74(21), 6271-6279. doi:10.1158/0008-5472.CAN-14-1656 [doi]
    Li, J., Pan, Q., Rowan, P. D., Trotter, T. N., Peker, D., Regal, K. M., . . . Yang, Y. (2016).,Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.,Oncotarget, 7(10), 11299-11309. doi:10.18632/oncotarget.7170 [doi]
    Nilsson, M. B., Armaiz-Pena, G., Takahashi, R., Lin, Y. G., Trevino, J., Li, Y., . . . Sood, A. K. (2007).,Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a src-dependent mechanism,The Journal of Biological Chemistry, 282(41), 29919-29926. doi:M611539200 [pii]
    Ruan, J., Trotter, T. N., Nan, L., Luo, R., Javed, A., Sanderson, R. D., . . . Yang, Y. (2013).,Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease,Bone, 57(1), 10-17. doi:10.1016/j.bone.2013.07.024 [doi]
    Sefah, K., Bae, K. M., Phillips, J. A., Siemann, D. W., Su, Z., McClellan, S., . . . Tan, W. (2013).,Cell-based selection provides novel molecular probes for cancer stem cells.,International Journal of Cancer.Journal International Du Cancer, 132(11), 2578-2588. doi:10.1002/ijc.27936 [doi]
    Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., . . . Marini, F. (2009).,Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression,PloS One, 4(4), e4992. doi:10.1371/journal.pone.0004992 [doi]
    Wang, M., Zhang, L., Han, X., Yang, J., Qian, J., Hong, S., . . . Yi, Q. (2007).,Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.,Blood, 109(12), 5455-5462. doi:blood-2006-12-063958 [pii]
    Zeng, Y., He, Y., Yang, F., Mooney, S. M., Getzenberg, R. H., Orban, J., & Kulkarni, P. (2011).,The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein.,The Journal of Biological Chemistry, 286(16), 13985-13994. doi:10.1074/jbc.M110.210765 [doi]
    Zhang, L., Yang, J., Qian, J., Li, H., Romaguera, J. E., Kwak, L. W., . . . Yi, Q. (2012).,Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.,Blood, 120(18), 3783-3792. doi:10.1182/blood-2012-04-424630 [doi]
    Buj, Raquel; Chen, Chi-Wei; Dahl, Erika S; Leon, Kelly E; Kuskovsky, Rostislav; Maglakelidze, Natella; Navaratnarajah, Maithili; Zhang, Gao; Doan, Mary T; Jiang, Helen; Zaleski, Michael; Kutzler, Lydia; Lacko, Holly; Lu, Yiling; Mills, Gordon B; Gowda, Raghavendra; Robertson, Gavin P; Warrick, Joshua I; Herlyn, Meenhard; Imamura, Yuka; Kimball, Scot R; DeGraff, David J; Snyder, Nathaniel W; Aird, Katherine M,Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming,Cell reports Vol.28, 2019
    Novy, Zbynek; Stepankova, Jana; Hola, Michaela; Flasarova, Dominika; Popper, Miroslav; Petrik, Milos;,Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme.,Molecules (Basel, Switzerland) Vol.24, 2019
    Vega, Francisco M; Colmenero-Repiso, Ana; Gómez-Muñoz, María A; Rodríguez-Prieto, Ismael; Aguilar-Morante, Diana; Ramírez, Gema; Márquez, Catalina; Cabello, Rosa; Pardal, Ricardo,D44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.,EBioMedicine Vol.49, 2019